Mercury Laboratories Limited

BSE: 538964
Mercury Laboratories Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L74239MH1982PLC026341 Incorporated 12 February 1982 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - BSE: 538964 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹75.94 Cr
▲ 1.11% YoY
Computed EBITDA · FY 2026
₹11 Cr
▲ 36.01% YoY
Net profit · FY 2026
₹4.83 Cr
▲ 53.71% YoY
Authorised capital
₹2.5 Cr
Registered with MCA
Paid-up capital
₹1.2 Cr
Issued & subscribed
Open charges
₹35.71 Cr
Satisfied ₹33.61 Cr
Company age
44 yrs
Est. 1982
Employees · EPFO
471
Latest available

About Mercury Laboratories Limited

Data last updated: 14 July 2026

Mercury Laboratories Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 12 February 1982, the company has been in operation for over 44 years.

Registered with ROC Mumbai under CIN L74239MH1982PLC026341. Listed on BSE: 538964.

Capital: an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹1.2 Cr. Formerly known as Mercury Laboratories Private Limited. It is led by directors including Rajendrakumar Ramanlal Shah and Paresh Jagdishbhai Mistry.

Last AGM: 13 August 2025. Financial statements filed for year ended 31 March 2025. Office: Shreeji Mang Idas Marketprincess Street, Mumbai, Maharashtra, India – 400002.

As per BSE-filed standalone financials for FY 2026, the company reported a revenue of ₹75.94 Cr, a growth of 1.11% compared to the previous year. The net worth stands at ₹58.08 Cr (up 8.41% YoY). Total assets are valued at ₹79.08 Cr (up 6.53% YoY).

The company has a workforce of approximately 471 employees as per the latest available data.

The company is associated with 1 brand - Mercury Laboratories. As per MCA filings, the company has open charges of ₹35.71 Cr and satisfied charges of ₹33.61 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mercurylabs.com.

Company Details of Mercury Laboratories Limited
CIN L74239MH1982PLC026341
Registration Number 026341
Incorporation Date 12 February 1982
ROC Mumbai
Listing Status Listed (BSE: 538964)
Company Status Active
Date of Last AGM 13 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Rajendrakumar Ramanlal Shah Managing Director Paresh Jagdishbhai Mistry Director Dilip Ramanlal Shah Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    mercurylabs.com
  • Social Media
  • Registered Address
    Shreeji Mang Idas Marketprincess Street, Mumbai, Maharashtra, India – 400002
  • Industry
    Pharma, Drug Formulation & Development
Company report
Mercury Laboratories Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Mercury Laboratories Limited report

Financials, compliance, directors, charges, ownership and filings for Mercury Laboratories Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Mercury Laboratories Limited

Mercury Laboratories Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L74239MH1982PLC026341, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L74239MH1982PLC026341 Current
U74239MH1982PTC026341 Previous
U74239MH1982PLC026341 Previous

Associated Brands with Mercury Laboratories Limited

Mercury Laboratories Limited operates one associated brand: Mercury Laboratories. These brands represent Mercury Laboratories Limited's diversified market presence and brand portfolio.

Brand Description Website
Mercury Laboratories
Pharmaceutical drugs are manufactured by Mercury Laboratories in India. mercurylabs.com

Business Activity of Mercury Laboratories Limited

Mercury Laboratories Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Mercury Laboratories Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Mercury Laboratories Limited

Mercury Laboratories Limited is audited by M/s NARESH AND CO (ICAI peer reviewed, certificate valid till 2027-10-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
M/s NARESH AND CO (ICAI peer reviewed, certificate valid till 2027-10-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Mercury Laboratories Limited

Mercury Laboratories Limited is currently managed by 6 directors, with 14 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Rajendrakumar Ramanlal Shah
Also directs: Mercury Laboratories Limited
Managing Director 16 Feb 1982 44 Years 6 Months Current
Paresh Jagdishbhai Mistry
Also directs: Mercury Laboratories Limited
Director 01 Oct 2017 8 Years 10 Months Current
Dilip Ramanlal Shah
Also directs: Mercury Laboratories Limited
Director 16 Feb 1982 44 Years 6 Months Current
Janki Rajendra Shah
Also directs: Mercury Laboratories Limited, Mercury Antibiotics Llp
Director 05 Feb 2020 6 Years 6 Months Current
Sanjay Patel
Also directs: Mercury Laboratories Limited, Ace Blue Ventures Llp, Aromix Private Limited and 4 more
Director 14 May 2025 1 Years 3 Months Current
Jayantilal Dhaneshwar Raval
Also directs: Mercury Laboratories Limited
Director 24 Jul 2024 2 Years 0 Months Current
View all directors

Financials of Mercury Laboratories Limited FY 2026 filings available

Mercury Laboratories Limited reported revenue of ₹75.94 Cr (up 1.11% YoY) for FY 2026.

Revenue · FY 2026
₹75.94 Cr ▲ 1.11%
Profit · FY 2026
₹4.83 Cr ▲ 53.71%
Computed EBITDA · FY 2026
₹11 Cr ▲ 36.01%
Revenue₹ Cr · Standalone050100FY 2019: ₹56 Cr55.5FY 2019FY 2020: ₹57 Cr · +3.1% YoY57.3+3.1%FY 2020FY 2021: ₹69 Cr · +19.8% YoY68.6+19.8%FY 2021FY 2022: ₹58 Cr · -15.6% YoY57.9-15.6%FY 2022FY 2023: ₹75 Cr · +30.1% YoY75.3+30.1%FY 2023FY 2024: ₹76 Cr · +0.3% YoY75.6+0.3%FY 2024FY 2025: ₹75 Cr · -0.6% YoY75.1-0.6%FY 2025FY 2026: ₹76 Cr · +1.1% YoY75.9+1.1%FY 2026
Net Profit₹ Cr · Standalone0246FY 2019: ₹3 Cr2.8FY 2019FY 2020: ₹3 Cr · +13.8% YoY3.2+13.8%FY 2020FY 2021: ₹5 Cr · +65.3% YoY5.3+65.3%FY 2021FY 2022: ₹4 Cr · -30.9% YoY3.7-30.9%FY 2022FY 2023: ₹6 Cr · +51.3% YoY5.6+51.3%FY 2023FY 2024: ₹6 Cr · +1.4% YoY5.7+1.4%FY 2024FY 2025: ₹3 Cr · -44.4% YoY3.1-44.4%FY 2025FY 2026: ₹5 Cr · +53.7% YoY4.8+53.7%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0102030Q1'25: ₹17 Cr16.7Q1'25Q2'25: ₹18 Cr18.2Q2'25Q3'25: ₹20 Cr19.6Q3'25Q4'25: ₹21 Cr20.7Q4'25Q1'26: ₹18 Cr · +8.7% YoY18.1+8.7%Q1'26Q2'26: ₹19 Cr · +4.5% YoY19+4.5%Q2'26Q3'26: ₹18 Cr · -6.2% YoY18.4-6.2%Q3'26Q4'26: ₹20 Cr · -1% YoY20.4-1%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹75.94 Cr ₹75.1 Cr ₹75.56 Cr ₹75.33 Cr ₹57.92 Cr ₹68.6 Cr ₹57.27 Cr ₹55.52 Cr
Other Income ₹1.96 Cr ₹1.07 Cr ₹1.09 Cr ₹1.72 Cr ₹81.59 Lakh ₹88.02 Lakh ₹84.95 Lakh ₹1.04 Cr
Total Income ₹77.89 Cr ₹76.17 Cr ₹76.65 Cr ₹77.05 Cr ₹58.74 Cr ₹69.48 Cr ₹58.12 Cr ₹56.56 Cr
Cost of Materials Consumed ₹25.36 Cr ₹27.45 Cr ₹28.09 Cr ₹28.57 Cr ₹21.83 Cr ₹29.48 Cr ₹23.07 Cr ₹23.33 Cr
Purchases of Stock-in-Trade ₹2.28 Cr ₹2.21 Cr ₹2.36 Cr ₹2.39 Cr ₹2.05 Cr ₹1.53 Cr ₹1.73 Cr ₹1.26 Cr
Changes in Inventories ₹1.89 Cr -₹74.27 Lakh -₹14.76 Lakh -₹54.52 Lakh -₹22 Lakh ₹15.88 Lakh ₹84.22 Lakh ₹1.75 Cr
Employee Benefit Expense ₹17.44 Cr ₹16.84 Cr ₹14.5 Cr ₹14.23 Cr ₹12.37 Cr ₹9.8 Cr ₹9.3 Cr ₹7.83 Cr
Finance Costs ₹54.48 Lakh ₹54.77 Lakh ₹38.3 Lakh ₹36.19 Lakh ₹44.64 Lakh ₹64.14 Lakh ₹81.75 Lakh ₹1.09 Cr
Depreciation & Amortisation ₹3.42 Cr ₹2.88 Cr ₹2.82 Cr ₹2.48 Cr ₹2.45 Cr ₹1.92 Cr ₹1.87 Cr ₹1.63 Cr
Other Expenses ₹19.94 Cr ₹22.33 Cr ₹21.72 Cr ₹22.12 Cr ₹14.78 Cr ₹18.04 Cr ₹16.16 Cr ₹15.63 Cr
Total Expenses ₹70.86 Cr ₹71.51 Cr ₹69.73 Cr ₹69.61 Cr ₹53.71 Cr ₹61.57 Cr ₹53.79 Cr ₹52.51 Cr
Profit Before Exceptional Items & Tax ₹7.03 Cr ₹4.66 Cr ₹6.92 Cr ₹7.44 Cr ₹5.03 Cr ₹7.91 Cr ₹4.33 Cr ₹4.05 Cr
Exceptional Items -₹39.49 Lakh ₹0 ₹0 ₹4.83 Lakh ₹12.75 Lakh ₹0 ₹0 ₹0
Profit Before Tax ₹6.64 Cr ₹4.66 Cr ₹6.92 Cr ₹7.49 Cr ₹5.16 Cr ₹7.91 Cr ₹4.33 Cr ₹4.05 Cr
Total Tax Expense ₹1.8 Cr ₹1.52 Cr ₹1.27 Cr ₹1.91 Cr ₹1.47 Cr ₹2.57 Cr ₹1.1 Cr ₹1.21 Cr
Net Profit ₹4.83 Cr ₹3.14 Cr ₹5.65 Cr ₹5.58 Cr ₹3.69 Cr ₹5.34 Cr ₹3.23 Cr ₹2.84 Cr
Other Comprehensive Income ₹9.33 Lakh ₹58,000 -₹2.45 Lakh ₹16.33 Lakh ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹4.93 Cr ₹3.15 Cr ₹5.63 Cr ₹5.74 Cr ₹3.69 Cr ₹5.34 Cr ₹3.23 Cr ₹2.84 Cr
EBITDA (computed) ₹11 Cr ₹8.09 Cr ₹10.12 Cr ₹10.29 Cr ₹7.93 Cr ₹10.47 Cr ₹7.02 Cr ₹6.77 Cr
Basic EPS ₹40.28 ₹26.21 ₹47.12 ₹46.49 ₹30.72 ₹44.48 ₹26.90 ₹23.64
Diluted EPS ₹40.28 ₹26.21 ₹47.12 ₹46.49 ₹30.72 ₹44.48 ₹26.90 ₹23.64
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹79.08 Cr ₹74.24 Cr ₹67.96 Cr ₹67.58 Cr ₹63.22 Cr ₹65.37 Cr ₹56.3 Cr ₹57.3 Cr
Non-current Assets ₹34.14 Cr ₹34.16 Cr ₹28.12 Cr ₹25.87 Cr ₹27.21 Cr ₹27.57 Cr ₹24.79 Cr ₹25.4 Cr
Current Assets ₹44.95 Cr ₹40.08 Cr ₹39.84 Cr ₹41.71 Cr ₹36.01 Cr ₹37.8 Cr ₹31.51 Cr ₹31.9 Cr
Property, Plant & Equipment ₹23.88 Cr ₹24.62 Cr ₹24.01 Cr ₹24.22 Cr ₹25.76 Cr ₹26.27 Cr ₹23.62 Cr ₹24.31 Cr
Inventories ₹7.12 Cr ₹7.21 Cr ₹6.21 Cr ₹6.9 Cr ₹6.78 Cr ₹5.16 Cr ₹5.51 Cr ₹6.78 Cr
Trade Receivables ₹25.85 Cr ₹25.74 Cr ₹21.85 Cr ₹21.37 Cr ₹17.54 Cr ₹22.54 Cr ₹18.14 Cr ₹19.29 Cr
Cash & Equivalents ₹80.32 Lakh ₹33.18 Lakh ₹3.29 Cr ₹3.71 Cr ₹4.11 Cr ₹3.03 Cr ₹1.3 Cr ₹28.58 Lakh
Equity (Net Worth) ₹58.08 Cr ₹53.57 Cr ₹50.84 Cr ₹45.63 Cr ₹40.34 Cr ₹36.89 Cr ₹31.98 Cr ₹28.97 Cr
Equity Share Capital ₹1.2 Cr ₹1.2 Cr ₹1.2 Cr ₹1.2 Cr ₹1.2 Cr ₹1.2 Cr ₹1.2 Cr ₹1.2 Cr
Borrowings (Non-current) ₹6.74 Cr ₹3.04 Cr ₹2.86 Cr ₹2.42 Cr ₹5.07 Cr ₹6.24 Cr ₹6.33 Cr ₹8.5 Cr
Borrowings (Current) ₹66.87 Lakh ₹1.05 Cr ₹2.63 Cr ₹2.94 Cr ₹0 ₹0 ₹0 ₹0
Total Debt (computed) ₹7.41 Cr ₹4.09 Cr ₹5.5 Cr ₹5.36 Cr ₹5.07 Cr ₹6.24 Cr ₹6.33 Cr ₹8.5 Cr
Current Liabilities ₹11.69 Cr ₹15.08 Cr ₹12.94 Cr ₹16.43 Cr ₹13.63 Cr ₹18.83 Cr ₹15.07 Cr ₹16.92 Cr
Total Liabilities ₹21.01 Cr ₹20.67 Cr ₹17.12 Cr ₹21.95 Cr ₹22.88 Cr ₹28.48 Cr ₹24.32 Cr ₹28.33 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹4.24 Cr ₹4 Cr ₹8.23 Cr ₹2.45 Cr ₹5.16 Cr
Investing Cash Flow -₹3.17 Cr -₹9.04 Cr -₹6.27 Cr -₹1.06 Cr -
Financing Cash Flow ₹2.91 Cr -₹99.45 Lakh -₹1.04 Cr -₹1.01 Cr -
Capital Expenditure ₹3.17 Cr ₹9.04 Cr ₹6.27 Cr ₹1.06 Cr -
Free Cash Flow (computed) ₹1.07 Cr -₹5.04 Cr ₹1.95 Cr ₹1.4 Cr -
Dividends Paid ₹42 Lakh ₹42 Lakh ₹42 Lakh ₹42 Lakh -
Net Change in Cash ₹3.99 Cr -₹6.03 Cr ₹91.14 Lakh ₹38.28 Lakh ₹5.16 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹20.44 Cr ₹18.35 Cr ₹19.01 Cr ₹18.14 Cr ₹20.66 Cr ₹19.57 Cr ₹18.19 Cr ₹16.68 Cr
Other Income ₹67.09 Lakh ₹31.24 Lakh ₹79.08 Lakh ₹18.1 Lakh ₹18.45 Lakh ₹52.9 Lakh ₹20.55 Lakh ₹14.98 Lakh
Total Income ₹21.11 Cr ₹18.66 Cr ₹19.8 Cr ₹18.32 Cr ₹20.84 Cr ₹20.1 Cr ₹18.4 Cr ₹16.83 Cr
Cost of Materials Consumed ₹6.9 Cr ₹6.3 Cr ₹6.22 Cr ₹5.94 Cr ₹8.15 Cr ₹7.12 Cr ₹7.54 Cr ₹4.65 Cr
Purchases of Stock-in-Trade ₹75.24 Lakh ₹57.67 Lakh ₹60.92 Lakh ₹33.78 Lakh ₹69.32 Lakh ₹63.31 Lakh ₹36.33 Lakh ₹51.59 Lakh
Changes in Inventories ₹19.29 Lakh ₹16.46 Lakh ₹56 Lakh ₹97.4 Lakh -₹79.12 Lakh -₹19.33 Lakh -₹1.09 Cr ₹1.33 Cr
Employee Benefit Expense ₹4.57 Cr ₹4.17 Cr ₹4.45 Cr ₹4.24 Cr ₹4.36 Cr ₹4.31 Cr ₹4.33 Cr ₹3.84 Cr
Finance Costs ₹13.05 Lakh ₹13.75 Lakh ₹13.21 Lakh ₹14.53 Lakh ₹13.12 Lakh ₹12.71 Lakh ₹15.13 Lakh ₹13.81 Lakh
Depreciation & Amortisation ₹84.39 Lakh ₹86.91 Lakh ₹86.32 Lakh ₹84.34 Lakh ₹72.95 Lakh ₹73.51 Lakh ₹71.28 Lakh ₹69.84 Lakh
Other Expenses ₹5.98 Cr ₹4.62 Cr ₹5.05 Cr ₹4.29 Cr ₹6.12 Cr ₹5.73 Cr ₹5.75 Cr ₹4.73 Cr
Total Expenses ₹19.38 Cr ₹16.84 Cr ₹17.88 Cr ₹16.77 Cr ₹19.4 Cr ₹18.46 Cr ₹17.75 Cr ₹15.91 Cr
Profit Before Exceptional Items & Tax ₹1.74 Cr ₹1.82 Cr ₹1.92 Cr ₹1.55 Cr ₹1.45 Cr ₹1.64 Cr ₹65.27 Lakh ₹91.93 Lakh
Exceptional Items ₹0 -₹39.49 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹1.74 Cr ₹1.43 Cr ₹1.92 Cr ₹1.55 Cr ₹1.45 Cr ₹1.64 Cr ₹65.27 Lakh ₹91.93 Lakh
Total Tax Expense ₹51.14 Lakh ₹43.23 Lakh ₹27.98 Lakh ₹57.97 Lakh ₹33.65 Lakh ₹45.02 Lakh ₹15.23 Lakh ₹57.78 Lakh
Net Profit ₹1.23 Cr ₹99.75 Lakh ₹1.64 Cr ₹96.76 Lakh ₹1.11 Cr ₹1.19 Cr ₹50.04 Lakh ₹34.15 Lakh
Other Comprehensive Income ₹7.47 Lakh ₹2.03 Lakh -₹33,000 ₹15,000 -₹1.72 Lakh ₹77,000 ₹92,000 ₹61,000
Total Comprehensive Income ₹1.3 Cr ₹1.02 Cr ₹1.64 Cr ₹96.91 Lakh ₹1.09 Cr ₹1.2 Cr ₹50.96 Lakh ₹34.76 Lakh
EBITDA (computed) ₹2.71 Cr ₹2.83 Cr ₹2.92 Cr ₹2.54 Cr ₹2.31 Cr ₹2.51 Cr ₹1.52 Cr ₹1.76 Cr
Basic EPS ₹10.21 ₹8.31 ₹13.69 ₹8.06 ₹9.25 ₹9.94 ₹4.17 ₹2.85
Diluted EPS ₹10.21 ₹8.31 ₹13.69 ₹8.06 ₹9.25 ₹9.94 ₹4.17 ₹2.85
Latest 8 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Mercury Laboratories Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Mercury Laboratories Limited

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 73.66%, retail and other public shareholders hold 26.34% of Mercury Laboratories Limited. The company had 1,316 shareholders on record.

Promoters: 73.66%Retail & Others: 26.34%
Mar 2026
QUARTER
73.66% Promoters
26.34% Retail & Others
Promoter holding - history
Now 73.66% · Mar 2026High 73.66% · Jun 2023Low 73.66% · Jun 2023
72%72.8%73.5%74.3%75%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 73.66%Sep 2023: 73.66%Dec 2023: 73.66%Mar 2024: 73.66%Jun 2024: 73.66%Sep 2024: 73.66%Dec 2024: 73.66%Mar 2025: 73.66%Jun 2025: 73.66%Sep 2025: 73.66%Dec 2025: 73.66%Mar 2026: 73.66%73.66%73.66%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters73.66%73.66%73.66%73.66%73.66%73.66%
Public26.34%26.34%26.34%26.34%26.34%26.34%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters73.66%73.66%73.66%
Public26.34%26.34%26.34%
Promoter change (YoY, %pts)+0.00+0.00-

Charges & Borrowings of Mercury Laboratories Limited

Open charges
₹35.71 Cr
Satisfied charges
₹33.61 Cr
Breakdown by lending institutions
Sidbi₹19.90 Cr
Hdfc Bank Limited₹15.81 Cr
Latest charge details
DateLenderAmountStatus
06 Mar 2026 Sidbi ₹18 Cr Open
19 Dec 2024 Sidbi ₹1.9 Cr Open
14 Mar 2024 Hdfc Bank Limited ₹20 Lakh Open
25 May 2023 Hdfc Bank Limited ₹50 Lakh Open
27 Sep 2021 Hdfc Bank Limited ₹7.06 Cr Open

Total charge records: 19 View all charges

Employees and EPFO Compliance at Mercury Laboratories Limited

Mercury Laboratories Limited has a workforce of 471 employees as of Oct 10, 2025.

Employee count
471
Active EPFO establishments
1
Employee growth
-3.09%
Premium access

Employee and EPFO history for Mercury Laboratories Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Mercury Laboratories Limited

Premium access

GST registrations and filing compliance for Mercury Laboratories Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Mercury Laboratories Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Mercury Laboratories Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Mercury Laboratories Limited

Premium access

MSME payment history for Mercury Laboratories Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Mercury Laboratories Limited

Premium access

Corporate group structure for Mercury Laboratories Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Mercury Laboratories Limited

Premium access

MCA filings and documents for Mercury Laboratories Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Mercury Laboratories Limited

Charges
06 Mar 2026
A charge with Sidbi amounted to Rs. 18.00 Cr with Charge ID 101257925 was registered on 06 Mar 2026.
Charges
06 Mar 2026
A charge with Sidbi of Rs. 18.00 Cr registered on 06 Mar 2026 with Charge ID 101257925 was modified on 06 Mar 2026.
Activity
13 Aug 2025
Mercury Laboratories Limited last Annual general meeting of members was held on 13 Aug 2025 as per latest MCA records.
Directors
14 May 2025
Sanjay Patel was appointed as a Director on 14 May 2025 & has been associated with this company since 1 year 3 months.
Activity
31 Mar 2025
Mercury Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
19 Dec 2024
A charge with Sidbi amounted to Rs. 1.90 Cr with Charge ID 101022958 was registered on 19 Dec 2024.

Frequently Asked Questions about Mercury Laboratories Limited

Mercury Laboratories Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 12 February 1982 (44+ years old) and is registered under CIN L74239MH1982PLC026341. Listed on BSE: 538964. The company has 471 employees.

Mercury Laboratories Limited reported revenue of ₹75.94 Cr for FY 2026 (up 1.11% YoY) based on standalone BSE filings.

The current directors of Mercury Laboratories Limited are:

The primary industry of Mercury Laboratories Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Mercury Laboratories Limited is listed on BSE with code 538964.

Mercury Laboratories Limited can be reached at the registered office: Shreeji Mang Idas Marketprincess Street, Mumbai, Maharashtra, India – 400002, or through the website mercurylabs.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available